Submission of Intimation of Website Address.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals Limited (formerly TRIMURTHI LIMITED, Scrip Code: 536565) has submitted an intimation to BSE disclosing its official website address as https://novelixpharma.com. The filing is made under Regulation 30 read with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company states the website contains information as required under Regulation 46. The disclosure is signed by Venkateshwarlu Pulluru, Whole-time Director, and dated 5th May, 2026. This is a routine compliance filing to formally notify the exchange of the company's website.
No material impact on the stock. This is a mandatory administrative disclosure confirming the company's online presence as required by SEBI listing rules. It does not convey any financial, operational, or strategic information.